在实验室中对被A-234抑制的人类复合性乙胆酶的重新激活查
Jakub Opravil1, Jaroslav Pejchal1, Martina Hrabinova2
1University of Defence, Military Faculty of Medicine, Department of Toxicology and Military Pharmacy, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic.
神经毒剂A-234需要长时间的氧化物治疗才能有效治疗. 在长时间的潜伏期后,HLö-7和 methoxime (MMB-4) 在重新激活抑制的乙胆酶方面表现最有前途.
科学领域:
- 毒理学 毒理学 毒理学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经毒剂A-234是一种诺维乔克,强烈抑制人类复合性乙胆酶 (HssAChE).
- 对A-234中毒的有效治疗是具有挑战性的,因为它具有不可逆转的抑制作用.
- 氧化物活性剂对于治疗神经毒剂中毒至关重要.
研究的目的:
- 选氧化物活性剂对A-234抑制的HssAChE.进行选.
- 为了比较抗 GB 和 VX 抑制酶的疗效.
- 为了确定最佳的治疗持续时间,并确定主要的重新激活器.
主要方法:
- 在体外查22个氧化物活性剂对A-234,GB和VX抑制的HssAChE.
- 化时间从10分钟到24小时不等.
- 在240分钟内对最有效的反应器进行动力分析.
主要成果:
- 没有氧化物在10分钟内有效地激活了A-234抑制的HssAChE.
- 在24小时化后,HLö-7,MMB-4,HI-6,K027,K868,TMB-4,GM415和LüH-6显示出有效性.
- HLö-7和MMB-4是最有效的,其中HLö-7显示出卓越的反应动力学.
结论:
- 对于A-234抑制的HssAChE的氧化反应,需要长时间的化.
- HLö-7和MMB-4是对A-234中毒的有希望的解药.
- 扩展治疗策略对于改善神经毒剂中毒的临床结果至关重要.
更多相关视频
11:01Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
